Back

Empagliflozin attenuates adverse outcomes of acute ischemic heart failure by targeting NLRP3/IL1β mediated macrophage polarization and inflammatory response

30 August 2026 (08:35 - 08:45)
Organised by: Logo
Congress Presentation Part of: Approaching heart failure therapy from all angles Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Guiquan Zhou

Xinqiao Hospital, Army Medical University, Chongqing (China)

5 More presentations in this session

Presentation thumbnail
Vutrisiran is associated with preservation of intrinsic capacity and healthy ageing in patients with transthyretin amyloidosis with cardiomyopathy: post hoc analysis of HELIOS-B
Professor O. Lairez (Toulouse, FR)
Abstract Slides Video
Presentation thumbnail
Machine learning approaches for the prediction of 1-year mortality after heart transplantation: a systematic review and meta-analysis
Doctor D. Mutahar (Gold Coast, AU)
Abstract Slides Video
Presentation thumbnail
Cardiac rehabilitation referral in heart failure units: clinical profile and outcomes from the Spanish National SEC-EXCELENTE-IC Registry
Doctor A. Esteban Fernandez (Leganes, ES)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes and one-year survival in heart transplant recipients from donors after circulatory death versus brain death: a meta-analysis of current evidence
Assistant Professor D. Garcia Maldonado (Ciudad de Mexico, MX)
Abstract Slides Video
Presentation thumbnail
Effectiveness of RSV vaccine against cardio-respiratory hospitalizations in heart failure: a prespecified analysis of the DAN-RSV trial
Doctor K. Skaarup (Copenhagen, DK)
Abstract Slides

Access the full session

Session thumbnail
Approaching heart failure therapy from all angles
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 08:35 CET
You may be interested in
thumbnail
Congress Presentation
Interference with NLRP3-inflammasome mediated signaling does not reduce myocardial ischemia reperfusion injury in a pig model of myocardial infarction
30 June 2021
thumbnail
Congress Presentation
Empagliflozin in a real-world chronic heart failure population
3 September 2019
thumbnail
Congress Presentation
Extracellular vesicle-mediated inflammatory reprogramming of macrophages in diabetic hyperglycemic environment.
29 August 2025
thumbnail
Congress Presentation
Anti-inflammatory protection of early vs delayed sodium-glucose cotransporter-2 inhibitor therapy on monocyte-derived macrophages from patients with type2 diabetes with acute myocardial infarction.
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources